Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KURA
#2592
Kura Oncology, Inc.
9.2
5
USD
+1.20%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+1.20%
Mudança mensal
+6.69%
Mudança em 6 meses
-10.89%
Mudança anual
+54.17%
Fechamento anterior
9.1
4
Abrir
9.2
3
Bid
Ask
Mínimo
9.1
9
High
9.2
7
Volume
72
Mercados
Ações
Cuidados de saúde
KURA
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
66.21 M
66.61 M
68.44 M
76.14 M
80.75 M
88.33 M
—
Valuation ratios
Enterprise value
1.84 B
846.18 M
782.04 M
1.14 B
488.44 M
778.36 M
2.42 B
Price to earnings ratio
—
—
-5.94
-7.38
-4.31
-3.27
-12.57
Price to sales ratio
—
—
—
—
13.93
13.5
—
Price to cash flow ratio
—
—
-7.33
-9.01
5.59
-14.22
3.14
Price to book ratio
—
—
1.92
2.83
1.81
5.23
6.49
Enterprise value to EBITDA ratio
—
-6.74
—
—
-2.4
-2.54
—
Profitability ratios
Return on assets %
-0.14
-0.24
-0.3
-0.34
-0.23
-0.38
-0.4
Return on equity %
-0.15
-0.26
-0.32
-0.38
-0.42
-1.6
-1.14
Return on invested capital %
-4 731.27
-4 261.24
-4 669.95
-4 398.28
-2 520.1
-1 522.22
-1 640.21
Gross margin %
—
100
—
—
100
100
400
Operating margin %
—
62.01 K
—
—
-358.55
-449.94
-1 817.07
EBITDA margin %
—
59.68 K
—
—
-380.39
-460.23
-1 860.26
Net margin %
—
61.54 K
—
—
-322.89
-412.95
-1 663.99
Liquidity ratios
Quick ratio
—
—
—
—
—
6.05
—
Current ratio
24.49
23.26
18.56
12.26
9.46
6.06
25.4
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
-0
—
—
0.09
0.09
0.1
Solvency ratios
Debt to assets ratio
0.01
0.01
0.02
0.02
0.01
0.01
0.06
Debt to equity ratio
0.01
0.01
0.02
0.02
0.02
0.06
0.15
Long term debt to total assets ratio
0.01
0.01
0.02
0.02
0.01
0.01
0.04
Long term debt to total equity ratio
0.01
0.01
0.02
0.02
0.02
0.06
0.12
Per share metrics
Operating cash flow per share
—
—
-1.64
-1.7
1.56
-0.73
-0.73
EBIT per share
—
—
—
—
-2.24
-3.46
-3.47
EBITDA per share
—
—
—
—
-2.38
-3.54
-3.55
Total debt per share
—
—
0.14
0.13
0.11
0.11
0.44
Cash per share
—
—
6.54
5.79
8.44
7.61
28.61
Net current asset value per share
—
—
6.66
5.91
8.64
8.08
30.99
Tangible book value per share
—
—
6.27
5.43
4.8
1.99
12.41
Working capital per share
—
—
6.3
5.42
7.73
6.75
26.02
Book value per share
—
—
6.27
5.43
4.8
1.99
12.41
Notícias
Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)
Mizuho reduz preço-alvo da Kura Oncology devido ao atraso nas vendas
UBS reduz preço-alvo da Kura Oncology para US$ 15
UBS lowers Kura Oncology stock price target to $15 on launch data
Kura Oncology na Conferência Global de Saúde da Leerink: insights sobre expansão estratégica
Kura Oncology at Leerink Global Healthcare Conference: Strategic Expansion Insights
Kura Oncology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KURA) 2026-03-06
Citizens reitera classificação de ações da Kura Oncology com lançamento forte
Citizens reiterates Kura Oncology stock rating on strong launch
Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates
Lucro da Kura Oncology Inc veio abaixo das projeções por $0,66; receita menor do que estimativas
Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates